European Heart Journal Supplements

Papers
(The TQCC of European Heart Journal Supplements is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
C86 ASSOCIATION OF PLASMA TMAO VALUES WITH ANOTHER ISCHEMIC EVENT DURING LONG–TERM FOLLOW–UP IN PATIENTS WITH MYOCARDIAL INFARCTION84
C48 TEN–YEARS, SINGLE–CENTER EXPERIENCE WITH MELODY TPV IMPLANTATION: EARLY OUTCOMES AND MID–TERM FOLLOW–UP66
P330 MANAGEMENT OF HYPERKALEMIA IN A PATIENT WITH HFREF65
P53 DOUBLE OUTLET RIGHT VENTRICLE IN PATIENT WITH XP11.23 DUPLICATION AND SYNDROMIC PHENOTYPE: BROADENING OF THE CLINICAL SPECTRUM54
P439 INTERPRETING CARDIOVASCULAR TRIALS WITH NEUTRAL OR NEGATIVE RESULTS TRIALS: A MULTISTEP APPROACH42
P4 TRANSTHYRETIN–INDUCED CARDIAC AMYLOIDOSIS: A RARE MUTATION IN AN ITALIAN FAMILIAL CASE40
P293 MULTI–DIMENSIONAL EVALUATION IN PATIENTS WITH AORTIC STENOSIS CANDIDATE FOR CARDIAC SURGERY36
P42 ACUTE STENT THROMBOSIS IN CATH LAB DURING OPTIMIZED PCI: HOW TO RECOGNIZE IT AND POSSIBLE TREATMENT32
P62 SEASON VARIABILITY IN ATHEROSCLEROSIS COMPOSITION: INSIGHTS FROM 1848 NON–CULPRIT CORONARY PLAQUES29
P152 CORONARY CT ANGIOGRAPHY A NEW PROMISING TOOL IN HEART TRANSPLANTED PATIENTS: FROM CLINICAL AND ECONOMICAL BENEFITS TO CORONARY INFLAMMATION DETECTION29
BETWEEN SCYLLA AND CHARYBDIS: MULTIPLE LEFT ATRIAL THROMBI DESPITE ORAL ANTICOAGULATION AND ANTIPLATELET THERAPY IN A PATIENT CANDIDATE FOR LEFT ATRIAL APPENDAGE OCCLUSION28
P175 PARADOXICAL RESPONSE DURING DOBUTAMINE STRESS ECHOCARDIOGRAPHY: A CASE REPORT28
THE CHALLENGING SCENARIO OF DYSPNEA IN THE ELDERLY: DUE MORE TO CONGESTION OR INFLAMMATION?27
SEVERE MITRAL REGURGITATION TREATED WITH TRANSCATHETER AORTIC VALVE IMPLANTATION IN MITRAL RING (TMVIR): A CASE REPORT27
SAFETY AND EFFICACY OF A SINGLE PROCEDURE OF EXTRACTION AND REIMPLANTATION OF INFECTED CARDIOVASCULAR IMPLANTABLE ELECTRONIC DEVICE (CIED) IN COMPARISON WITH DEFERRAL TIMING: AN OBSERVATIONAL RETROSPE25
MITRACLIP TREATMENT FOR CARDIOGENIC SHOCK DUE TO ACUTE MITRAL REGURGITATION IN A PATIENT WITH POSTINFARCTION PAPILLARY MUSCLE RUPTURE22
CONTRAST STRESS ECHOCARDIOGRAPHY FINDINGS IN MYOCARDIAL BRIDGING COMPARED TO NORMAL CORONARY COURSE, WITH AND WITHOUT CORONARY ARTERY DISEASE21
OUT–OF–HOSPITAL MANAGEMENT INDICATORS IN THE APPLICATION OF THE UNIFIED PDTA "STEMI NETWORK" FOR THE AST OF ASCOLI PICENO AND FERMO: FROM DIAGNOSIS TO PCI WIRE–CROSSING. LONGITUDINAL OBSERVATIONAL CLI21
DENGUE MYOCARDITIS IN A DECEASED PATIENT WITH POSTMORTEM POSITIVE DENGUE SEROLOGY21
SYNCOPE OF UNCERTAIN NATURE20
P272 ROLE OF 3D TRANSESOPHAGEAL ECHOCARDIOGRAPHY IN DIANOSIS OF DYSFUNCTION OF MECHANICAL PROSTHESES20
P50 ODD CONNECTIONS20
ACUTE PULMONARY EMBOLISM: NEW HORIZONS IN CAT LAB19
Moodle as online platform for cardiac nurses’ competency: nursing staff experiences19
AN ISOLATED ACUTE RIGHT VENTRICULAR INFARCTION19
P135 A CASE OF RIGHT CORONARY ARTERY ANEURYSM COMPLICATED BY ENDOVASCULAR THROMBOSIS19
Cardiovascular risk stratification in cancer survivors: time for a better approach?18
Anthracycline exposure alters the response to future cardiac stress response driven by FOXK118
Snapshot of cardio-oncology practice in Italy18
Looking beyond LVEF: cardiac and skeletal muscle function in long-term breast cancer survivors with normal versus reduced peak oxygen uptake18
Early detection of cardiac dysfunction in patients with breast cancer receiving antitumor therapy18
IDENTIFYING CARDIOGENIC SHOCK SUB–PHENOTYPES WITH MACHINE LEARNING: A MULTICENTER STUDY COMBINING CLINICAL AND ECHOCARDIOGRAPHIC DATA17
UTILITY OF INTRA–PROCEDURAL HIGH–DENSITY MAPPING TO IDENTIFY SUBOPTIMAL PULMONARY VEIN ISOLATION WITH PULSED–FILED ABLATION: A SINGLE–CENTER EXPERIENCE17
NURSE–LED AMBULATORY CARE PATHWAY IN HEART FAILURE: IMPROVING OUTCOMES AND QUALITY OF LIFE17
REMOTE MONITORING OF HEART FAILURE PARAMETERS AFTER ATRIAL FIBRILLATION ABLATION WITH PULSED–FILED ENERGY: AN EXPLORATORY ANALYSIS17
IMPACT OF INTERMITTENT LEVOSIMENDAN INFUSIONS ON HEART TRANSPLANTATION17
Immune checkpoint inhibitor-associated myocarditis: diagnostic challenges17
Chemotherapy induced- right ventricular dysfunction in non-Hodgkin lymphoma: a 3D echocardiographic study17
RATE–RELATED LEFT BUNDLE BRANCH BLOCK IN A HIGHLY ACTIVE INDIVIDUAL: A COMPREHENSIVE WORKUP PROVIDES AN UNEXPECTED DIAGNOSIS17
EFFICACY OF PERCUTANEOUS STELLATE GANGLION BLOCK IN PATIENTS WITH ARRHYTHMIC STORM: WHICH ROLE DO ANAESTHETICS PLAY? DATA FROM A MULTICENTRE CASE STUDY16
A CASE OF PROSTHETIC VALVE ENDOCARDITIS: WHEN PNEUMONIA IS NOT THE RIGHT ANSWER16
RECURRENT DISSECTION OF LEFT CORONARY ARTERY WITH EXTENSION TO THE LEFT MAIN AND CARDIOGENIC SHOCK16
YOUNGER PATIENTS WITH LOW BLOOD HEMOGLOBIN LEVELS DURING ACUTE CORONARY SYNDROME HAVE HIGHER GLOBAL MORTALITY RISK THAN THE ELDERLY IN THE LONG–TERM FOLLOW UP15
489 A RARE CASE OF LEAD EXTRACTION14
WEARABLE CARDIOVERTER DEFIBRILLATOR: ADHERENCE AND IMPACT ON PERCEIVED HEALTH STATUS IN A SINGLE CENTRE EXPERIENCE14
269 EFFECTS OF COLCHICINE TREATMENT AFTER MYOCARDIAL INFARCTION ON TOP OF STANDARD THERAPY: EVIDENCE FROM A PRECLINICAL STUDY14
ASSOCIATION BETWEEN REGULAR SPORT ACTIVITY AND RESTING HEART RATE VALUES IN A CROSS–SECTIONAL ADOLESCENT STUDY14
POST–TRAUMATIC CORONARY DISSECTION: A RARE BUT POTENTIALLY LETHAL EVENT14
WORKING GROUP FOR THE MANAGEMENT OF DYSLIPIDEMIA IN PATIENTS WITH ACUTE CORONARY SINDROMES: A TAILORED APPROACH14
490 NT-PROBNP AND HIGH-SENSITIVITY TROPONIN T HOLD DIAGNOSTIC VALUE IN CARDIAC AMYLOIDOSIS13
937 INCIDENTAL DIAGNOSIS OF ANOMALOUS ORIGIN AF A CORONARY ARTERY: BETTER LATE THAN NEVER.13
180 LONG TERM FOLLOW UP OF A NON-PROGRESSIVE LEFT MAIN CORONARY ARTERY FISTULA TO RIGHT ATRIUM13
361 PATISIRAN EFFICACY ON MYOCARDIAL FUNCTION IN H-ATTR PATIENTS EVALUATED WITH THE USE OF CMR AND SPECKLE TRACKING ECOCARDIOGRAPHY13
784 IMPACT OF ELECTIVE, UNCOMPLICATED TARGET LESION REVASCULARIZATION ON CARDIAC MORTALITY AFTER ELECTIVE PERCUTANEOUS CORONARY INTERVENTION OF UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE12
88 INCIDENTAL DIAGNOSIS OF MASSIVE MOBILE LEFT VENTRICLE THROMBI FOLLOWING COVID-19 INFECTION IN A HEART FAILURE PATIENT12
672 TRANSCATHETER VS SURGICAL TREATMENT FOR PERCEVAL DEGENERATION: TAILORED STRATEGY FROM THE HEART TEAM12
366 RIGHT HEART FAILURE IN CARCINOID HEART DISEASE: A MULTIDISCIPLINARY APPROACH12
752 CARDIOGENIC SHOCK AS THE FIRST PRESENTATION OF ACUTE ANTRACYCLINE CARDIOTOXICITY: A CLINICAL CASE11
1082 LEFT VENTRICULAR FUNCTION ESTIMATION: WHEN VOLUMES MEASUREMENT IS NOT FEASIBLE11
1094 MULTIVESSEL CORONARY ARTERY SPASM TRIGGERED BY GANGLIONATED PLEXI STIMULATION DURING ATRIAL FIBRILLATION RADIOFREQUENCY CATHETER ABLATYION: A CASE REPORT11
456 NATURAL HISTORY AND CLINICAL BURDEN OF MODERATE AORTIC STENOSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS11
373 ADONHERS (AGED DONOR HEART RESCUE BY STRESS ECHO) PROTOCOL FOR HEART DONATION FROM MARGINAL DONOR HEARTS: MONOCENTRIC RETROSPECTIVE STUDY ON RECIPIENT'S SURVIVAL AFTER 10-YEAR FOLLOW-UP11
1129 IMAGING STRESS TEST OR CORONARY COMPUTED TOMOGRAPHY PRIOR TO NON-CARDIAC SURGERY? A SEVEN YEARS SINGLE CENTRE EXPERIENCE11
346 IMPACT OF EXERCISE-INDUCED PULMONARY HYPERTENSION ON THE RIGHT VENTRICLE AND WORSENING OF CARDIOVASCULAR RISK IN HIV PATIENTS11
835 CARDIOMYOPATHIES: IS IT USEFUL TO ANALYZE MINOR GENES?11
270 PARTICULAR MISDIAGNOSED ACS-NSTEMI IN A YOUNG ADULT WITH HISTORY OF HODGKIN'S LYMPHOMA IN THE ERA OF FREQUENT SARS-COV2 RELATED MYOCARDITIS: NOTHING SHOULD EVER BE LEFT TO CHANCE.11
633 THE EFFECTS OF AEROBIC EXERCISE TRAINING ON CARDIOPULMONARY EXERCISE TESTING AND HEART FAILURE BIOMARKERS IN ADULT PATIENTS WITH HYPOPLASTIC LEFT HEART SYNDROME AND FONTAN CIRCULATION10
C81 ROLE OF RESTRICTIVE DIASTOLIC DYSFUNCTION FOR RISK STRATIFICATION OF PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY: A BAYESIAN MODEL AVERAGING10
Challenges in diagnosing and treating iatrogenic pulmonary vein stenosis: a novel percutaneous approach10
Seeking and treating inflammation in ischaemic heart disease: are we ready?10
731 MULTICENTRE OBSERVATIONAL REGISTRY OF PATIENTS HOSPITALIZED FOR HEART FAILURE AND REAL-LIFE ADHERENCE TO INTERNATIONAL GUIDELINES FOR THE MANAGEMENT OF PATIENTS WITH ACUTE AND CHRONIC HEART FAILUR10
DIAGNOSTIC CRITERIA FOR NON–DILATED LEFT VENTRICULAR CARDIOMYOPATHY WITH PROGNOSTIC SIGNIFICANCE10
Assessment of Myocardial Viability by Speckle Tracking in Patients with Late Presentation Acute Myocardial Infarction10
May Measurement Month 2021: an analysis of blood pressure screening campaign results from India10
185 BETA-BLOCKERS OR CALCIUM CHANNEL BLOCKERS IN HYPERTROPHIC CARDIOMYOPATHY10
A new application of computed tomography: stereotactic radiotherapy in the treatment of ventricular arrhythmias10
Assessment of cardiac functions using two-dimensional transthoracic and speckle tracking echocardiography after treatment with SGLT2 inhibitors in Patients with HFrEF9
May Measurement Month 2023: results of an opportunistic blood pressure screening campaign in South Africa9
Focus on lipoprotein(a)9
P321 NEOVASC REDUCER IMPLANTATION AS A USEFUL THERAPEUTIC CHANCE IN REFRACTORY ANGINA9
Unlocking the enigma: decoding premature ventricular complexes for effective clinical assessment and risk management9
Treatment of acute pulmonary embolism: anticoagulation, fibrinolysis, and thrombectomy compared9
Is it possible that angioplasty does not improve the quality of life in patients with stable angina?9
Myocardial infarction and viral triggers: what do we know by now?9
The comeback of digitalis (digitoxin): the DIGIT-HF trial9
C77 GENDER GAP IN TIME TO ST–ELEVATION MYOCARDIAL INFARCTION DIAGNOSIS: A RETROSPECTIVE COHORT STUDY8
P117 TRANSCATHETER AORTIC VALVE REPLACEMENT IN PATIENTS WITH CHRONIC THROMBOCYTOPENIA: PREVALENCE AND IN–HOSPITAL OUTCOMES8
P413 A CASE OF PERIPARTUM DILATED CARDIOMYOPATHY WITH SEVERE BIVENTRICULAR DYSFUNCTION8
P234 IT IS TIME THAT ITALIAN AMI NETWORKS ARE BASED ON DIAGNOSTIC–THERAPEUTIC PATHWAYS INCLUDING BOTH TYPES OF ACS (STEMI AND NSTEMI)8
P464 ELEVATED SPONTANEOUS INR: THE COMPLEXITY OF REAL LIFE BETWEEN CARDIOLOGY AND HEMATOLOGY8
P245 IMPLICATIONS IN PHARMACOLOGICAL AND ELECTRICAL OPTIMIZATION IN HEART FAILURE: A EMBLEMATIC CASE8
P312 TAKOTSUBO SYNDROME DURING INFECTIVE ENDOCARDITIS: AN UNUSUAL COMBINATION8
P130 FINGER ISCHEMIA IN A YOUNG LADY: EXPECT THE UNEXPECTED FROM A PAPILLARY FIBRO–ELASTOMA8
P178 OCCASIONAL ECHOCARDIOGRAPHIC DIAGNOSIS OF BRONCHOGENIC CYST8
P255 A GOOD PERSPECTIVE NEEDS TWO POINT OF VIEW: TRANSVENOUS CRT–D LEAD EXTRACTION COMPLICATED BY INTRAOSSEUS COURSE OF THE CORONARY SINUS LEAD8
OUTCOME OF OUT OF HOSPITAL CARDIAC ARREST: ARE THERE GENDER DIFFERENCES?7
THE EFFICACY OF VERY LOW CALORIE KETOGENIC DIET (VLCKD) ON CARDIO–METABOLIC PROFILE IN PATIENTS WITH OBESITY7
P224 THE SHARK–FIN THAT EMERGES AND IMMERGES: A CASE REPORT OF TRANSIENT AND REPETITIVE TRIANGULAR QRS–ST–T7
SEVERE SYMPTOMATIC MITRAL REGURGITATION AFTER ANNULOPLASTY FAILURE: SUCCESSFUL TRANSCATHETER EDGE TO EDGE REPAIR7
GUIDEWIRE SHAPE MODIFICATION: A SIMPLE TECHNIQUE TO PREVENT CONDUCTION SYSTEM INJURIES DURING TRANSCATHETER VALVE IMPLANTATION7
YOUNG WOMAN WITH LEFT VENTRICULAR DYSFUNCTION AND MITRAL LAMBL EXCRESCENCE: WHAT TO DO WHEN ISCHEMIC STROKE IS RECURRENT?7
CASE REPORT: SELF–EXPANDING TRANSCATHETER VALVE IMPLANTATION (ACURATE NEO 2) IN A VERY SMALL NATIVE AORTIC ANNULUS7
P238 THE HEART LOGIC EXPERIENCE IN OUR CENTER “SANTA MARIA DELLA MISERICORDIA” HOSPITAL, UDINE7
SODIUM–GLUCOSE COTRANSPORTER 2 INHIBITOR DAPAGLIFLOZIN REDUCES SYSTEMIC H–FABP AND MONOCYTE–TO–LYMPHOCYTE RATIO IN PRECLINICAL MODELS OF ANTRACYCLINE INDUCED CARDIOTOXICITY7
EXPLORING THE 12 LEAD ECG CHARACTERISTIC OF PAEDIATRIC AND YOUNG ADULT CARRIERS OF DESMOPLAKIN GENE VARIANTS7
HALF DOSE THROMBOLYSIS IN INTERMEDIATE – HIGH RISK PULMONARY EMBOLISM WITH TRICUSPID VALVE MOBILE MASS: A BAIL OUT STRATEGY7
P46 TRANSAXILLARY MITRAL VALVE SURGERY IS ASSOCIATED WITH EARLY RECOVERY AND SHORTER ICU AND HOSPITAL STAY7
LONG–TERM FUNCTIONAL LIMITATIONS ON CARDIOPULMONARY EXERCISE TESTING IN A COHORT OF PATIENTS WITH EMOTIONS–TRIGGERED TAKOTSUBO SYNDROME7
RESIDUAL CARDIOVASCULAR RISK AND SEVERITY OF CORONARY DISEASE7
LIPID–LOWERING THERAPY WITH PCSK9 INHIBITORS: FAMILIAL HYPERCHOLESTEROLEMIA VS GENERAL POPULATION OUTCOMES6
A CASE OF DUAL–SITE LEFT VENTRICULAR PACING PERFORMED VIA A PERSISTENT LEFT SUPERIOR VENA CAVA IN A PATIENT WITH COMPLETE ATRIO–VENTRICULAR BLOCK AND RIGHT SUPERIOR VENA CAVA OCCLUSION6
TELECUORE: FEASIBILITY OF A HOSPITAL–TERRITORIAL TELEMEDICINE PROJECT IN CHRONIC HEART FAILURE6
ADVANCED CARDIAC IMAGING IN LIVER TRANSPLANTATION ECHOCARDIOGRAPHIC VENTRICULAR STRAIN AS PROGNOSTIC TOOLS6
PREDICTING ADVERSE OUTCOMES IN HYPERTROPHIC CARDIOMYOPATHY:THE PIVOTAL ROLE OF CARDIOPULMONARY EXERCISE TESTING6
HYPERTENSIVE EMERGENCIES AND URGENCIES: ADHERENCE TO GUIDELINES AND RELATIONSHIP BETWEEN BLOOD PRESSURE MANAGEMENT AND IN–HOSPITAL MORTALITY6
PROGNOSTIC VALUE MEAN PULMONARY ARTERIAL PRESSURE AND PULMONARY VASCULAR RESISTANCE IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION AT FOLLOW–UP6
THE OUTPATIENT CLINIC FOR PATIENTS WITH HEART FAILURE: A PROPOSAL FOR ADVANCED NURSING6
ROLE OF THE NURSE IN MANAGING INVASIVE BLOOD PRESSURE MONITORING6
TRANSTYRETIN CARDIAC AMYLOIDOSIS IN ELDERLY PATIENTS: ALWAYS A WILD TYPE?6
Scenarios in precision medicine: proteomics in heart failure6
DON’T FORGET ABOUT CARDIAC AMYLOIDOSIS: WHEN RED FLAGS MATTER6
ACUTE MYOCARDIAL INJURY IN A PATIENT WITH TYPE–1 NEUROFIBROMATOSIS: A CASE OF SUSPECTED PHEOCROMOCYTOMA–ASSOCIATED MYOCARDITIS6
THE HEART‘S ABILITY TO "SELF–DEFIBRILLATE": A SPECIAL CASE OF IDIOPATHIC VENTRICULAR TACHYCARDIA6
REAL–WORLD SOTATERCEPT ELEGIBILITY: ANALYSIS FROM FOCUS–PAH REGISTRY6
30 EVOLOCUMAB USE IN CLINICAL PRACTICE IN ITALY: FINAL DATA OF THE HEYMANS STUDY.6
395 ASSESSMENT OF VENTRICULAR ARRHYTHMIAS IN PATIENTS UNDERGOING TRANCATHETER AORTIC VALVE IMPLANTATION (TAVI): IMPACT ON CLINICAL OUTCOME5
647 COMPLEX PERCUTANEOUS CORONARY INTERVENTION IN HIGHT BLEEDING AND THROMBOTIC RISK PATIENT: WHICH ANTITHROMBOTIC THERAPY?5
722 NATURAL ACTIVATORS OF AUTOPHAGY PROTECT THE HEART FROM DOX-INDUCED CARDIOMYOPATHY5
1153 SODIUM GLUCOSE COTRANSPORTER-2 INHIBITORS ELIGIBILITY IN PATIENTS WITH HEART FAILURE ACROSS THE SPECTRUM OF EJECTION FRACTION5
890 ARTIFICIAL INTELLIGENCE EMPOWERS REMOTE MONITORING OF IMPLANTABLE LOOP RECORDERS5
676 A PITFALL IN ECHOGRAPHIC DIAGNOSIS OF ABDOMINAL AORTIC ANEURYSM: WHEN PARA-AORTIC LYMPH NODES REQUIRE ATTENTION5
INTERDEPARTMENTAL CLINICAL PATHWAY FOR THE MANAGEMENT OF HYPERCHOLESTEROLEMIA IN PRIMARY AND SECONDARY PREVENTION5
THE ADDING VALUE OF NON–INVASIVE ASSESSMENT OF STROKE VOLUME DURING CARDIOPULMONARY EXERCISE TESTING IN HYPERTROPHIC CARDIOMYOPATHY: BEYOND O2–PULSE5
54 EXPLORING FEATURES AND OUTLOOK OF WOMEN DISCHARGED AFTER AN ACUTE CORONARY SYNDROME MANAGED INVASIVELY: INSIGHTS FROM THE 23,072 PATIENTS PRAISE MULTICENTER REGISTRY5
829 IMPACT OF SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS ON CARDIAC REMODELLING IN LOW RISK PATIENTS WITH TYPE 2 DIABETES MELLITUS5
682 UNEXPECTED TRIGLYCERIDES-LOWERING EFFECT OF A NOVEL NUTRACEUTICAL COMPOUND FOR IBS5
162 HFREF WITH IMPROVED EJECTION FRACTION AFTER CORONARY ARTERY BYPASS GRAFT (CABG) AND REVERSE REMODELING PREDICTOR FACTORS5
1106 CLINICAL AND MULTIMODAL IMAGING FOLLOW-UP OF PATIENTS WITH MYOPERICARDITIS FOLLOWING MRNA COVID-19 VACCINATION5
534 PROGNOSTIC IMPACT OF CONTRAST-INDUCED ACUTE KIDNEY INJURY IN OLDEST OLD STEMI PATIENTS: A MULTICENTER REGISTRY5
85 ATRIAL FIBRILLATION INCIDENCE IN SARS-COV-2 INFECTED PATIENTS: PREDICTORS AND RELATIONSHIP WITH IN-HOSPITAL MORTALITY5
1066 THE USEFULNESS OF CEREBRAL PROTECTION DURING TAVR: A METANALYSIS5
216 ARRHYTHMOGENIC CARDIOMYOPATHY: IS THERE EVIDENCE OF AN INFLAMMATORY MYOCARDIAL DISEASE?5
587 LEFT ATRIAL APPENDAGE OCCLUSION: A REAL SOLUTION TO CARDIOEMBOLIC RISK OF ATRIAL FIBRILLATION?5
111 POST-OPERATIVE OUTCOME OF ADULT PATIENTS WITH PRE-TRICUSPID SHUNT UNDERGOING DEFECT CLOSURE5
43 CARDIAC TROPONINS AND COVID-19: WHAT DO WE KNOW ABOUT HETEROPHILIC ANTIBODIES?5
665 THE UNFORSEEN MECHANISM: A CASE OF DISTRIBUTIVE SHOCK SECONDARY TO REACTIVE HAEMOPHAGOCYTIC SYNDROME LEADING TO SEVERE REVERSIBLE BIVENTRICULAR DYSFUNCTION.5
1026 MYOCARDIAL INFARCTION AND STROKE IN A YOUNG PATIENT AFFECTED BY LES: KEY ROLE OF AN INTEGRATED IMAGING APPROACH5
3D strain echocardiography in detection of subclinical left ventricle dysfunction as a marker of early-onset anthracycline cardiotoxicity among children treated for acute lymphoblastic leukemia4
Tailoring antiplatelet therapy duration after PFO closure: insights from the PROLONG registry4
1054 GENDER DIFFERENCES IN MINOCA POPULATION4
Digitally enabled cardiac rehabilitation following coronary revascularization: results from a single centre feasibility study4
How an innovative catheter with temperature control and very high-power, short-duration ablation changed our approach to the treatment of persistent atrial fibrillation4
May Measurement Month 2021: an analysis of blood pressure screening results from the Philippines4
May Measurement Month 2022: an analysis of blood pressure screening results from Kazakhstan4
BASAL AND POST–STRESS CERT1 RISK SCORE PREDICTS ALL–CAUSE MORTALITY AND NONFATAL MYOCARDIAL INFARCTION IN PATIENTS WITH ESTABLISHED OR SUSPECTED CORONARY ARTERY DISEASE UNDERGOING STRESS MYOCARDIAL PE4
CARDIAC MAGNETIC RESONANCE IN A CASE OF RECURRENT MESALAZINE–INDUCED MYOCARDITIS4
Disparities between cardiologists and oncologists therapeutic strategies in cardio-oncology. A national cross-sectional survey4
Cardiomyocyte-derived exosomes: linking heart failure to tumour progression4
EFFICACY AND SAFETY OF INCLISIRAN IN OUTPATIENTS WITH RECENT ACUTE CORONARY SYNDROME4
Cardiovascular follow-up outpatient clinic and cardiovascular follow-up notebook for cancer survivor4
253 EXCERCISE-INDUCED PULMONARY HYPERTENSION AND CORONARY ARTERY ANOMALY: AN UNUSUAL ASSOCIATION4
Validation and comparison of prognostic scores for severe tricuspid regurgitation4
Cardio-oncology blitz registry offers real-world data in a gastrointestinal cancer population4
MYOCARDITIS CAUSED BY GRANULOCYTE COLONY STIMULATING FACTOR ADMINISTRATION IN A HEALTHY HEMATOPOIETIC STEM CELLS DONOR: A CASE REPORT4
CLINICAL ADVANTAGE OF THE USE OF ADVANCED ALGORITHMS FOR THE MANAGEMENT OF HEART FAILURE IN PATIENTS UNDERGOING IMPLANTATION OF CARDIAC CONTRACTILITY MODULATION DEVICES4
Critical analysis of the 2023 ESC guidelines on cardiomyopathy management4
Old and new therapeutic solutions in the treatment of hypertrophic cardiomyopathy4
CONTEMPORARY OUTCOMES OF DEGENERATIVE MITRAL VALVE SURGERY IN A REGIONAL TERTIARY CARE CENTER4
Cell painting based high-content phenotypic screening to elucidate kinase signaling pathways in ibrutinib-mediated atrial fibrillation4
The advantages of physiological pacing4
139 INTRAVENOUS CONTINUOUS HOME INOTROPIC THERAPY IN ADVANCED HEART FAILURE - RESULTS AND PRACTICAL GUIDELINES4
When anticoagulant therapy is not enough: recurrent stroke4
Baseline physiologic characteristics of participants in the APOLLO ( Personalized rehAbilitation PrOgram in aLLOgeneic Bone Marrow Transplantation) study assessed by MRI: preliminary results4
SURGICAL MANAGEMENT OF QUADRICUSPID AORTIC VALVE4
ELECTROANATOMIC ACTIVATION MAPPING OF KOCH TRIANGLE IN AVNRT PATIENTS4
When Brugada syndrome is at risk of sudden death: clinical and anatomical aspects4
FRACTIONATED PROCEDURAL RISK OF MORTALITY IN A VERY FRAIL PATIENT: CASE REPORT OF A TAILORED HYBRID APPROACH4
Accessory Fascicolo-Ventricular Pathway in Hypertrophic Phenotype Cardiomyopathy Suspected for Prkag2 Mutation: Diagnostic Role of Myocardial Biopsy3
991 A PATIENT WITH INFERIOR Q WAVES AND CHEST PAIN: WHEN HOOF BEATS ARE NOT HORSES3
588 EXPLORING THE IMPACT OF SEVERE SECONDARY TRICUSPID REGURGITATION ON REST AND EXERCISE HEMODYNAMICS OF PATIENTS WITH HEART FAILURE AND A PRESERVED LEFT VENTRICULAR EJECTION FRACTION3
Pattern of cardiovascular admission diagnoses during the month of Ramadan: a single center experience3
Procedural safety and mid-term outcomes after valve-in-valve transcatheter aortic valve implantation: a prospective single-center study3
Territorial longitudinal strain and regional RCA myocardial work in patients with chronic coronary syndrome and presence of right coronary artery total chronic occlusion3
State-of-the-art practice in 3VD CAD combining predictive score, contemporary CTO expertise, angiography-derived physiology, intravascular Imaging and P2Y12 mono therapy: The Multivessel TALENT3
113 RIGHT VENTRICULAR FREE WALL LONGITUDINAL STRAIN AS THE SOLE MARKER OF RIGHT VENTRICLE SYSTOLIC DYSFUNCION IN HYPERTROPHIC CARDIOMYOPATHY: A CLINICAL CASE3
INVERTED T–WAVES AND CORONARY ANEURYSMS: THE HIDDEN DRAMA OF A ROUTINE EVALUATION3
Effect of statin on right ventricle function in breast cancer patients treated with anthracycline3
Mycophenolate mofetil as second-line therapy for steroid-refractory ICI-induced myocarditis3
CARDIAC MEMORY PRESENTING AS ST ELEVATIONS FOLLOWING REENTRANT SUPRAVENTRICULAR TACHYCARDIAS3
Reduction of cerebrovascular and peripheral events with PCSK9 inhibitors: Does it just depend on the lowering of the low-density lipoprotein?3
654 ECHOCARDIOGRAPHIC PARAMETERS AND CLINICAL OUTCOMES IN HEART FAILURE WITH PRESERVED EJECTION FRACTION AND CORONARY MICROVASCULAR DYSFUNCTION: A SYSTEMATIC REVIEW AND META-ANALYSIS3
745 INTERDISCIPLINARY EVALUATION IN RESISTANT ARTERIAL HYPERTENSION3
421 CARDIO-NEURO ABLATION WORKFLOW OPTIMIZATION USING THE CARTO 3 SYSTEM CFAE MODULE3
The impact of COVID-19 and COVID vaccination on cardiovascular outcomes3
Outcomes of transradial versus transfemoral secondary access in transcatheter aortic valve implantation: a systematic review and meta-analysis3
Biomimetic CD31-coated stent maintains physiological performance under high barotrauma in pigs3
532 SEX-RELATED DIFFERENCES IN THROMBUS BURDEN IN ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION3
661 TWO CARDIOMYOPATHIES IN ONE HEART: LESSONS FROM CLINICAL CASE3
REVEALING THE PROGNOSTIC ACCURACY OF DIFFERENT GLOMERULAR FILTRATION RATE ESTIMATION FORMULAS IN HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION AND VARIOUS DEGREES OF KIDNEY FAILURE: THE RENAL–3
Gut microbiome correlations with cardiotoxicity biomarkers (LV-GLS, LVEF, Troponin I, NTproBNP) in breast cancer patients prior to chemotherapy3
Impact of a multimodal prehabilitation program on the cardiovascular risk profile of high-risk oncologic and non-oncologic patients undergoing major colorectal surgery3
354 THE ADDED VALUE OF MYOCARDIAL WORK IN EARLY DETECTION OF SYSTOLIC DYSFUNCTION IN CARDIAC AMYLOIDOSIS3
Pollution and coronary risk: how much does it matter?3
326 STAGED ENDOVASCULAR TREATMENT FOR MULTIVALVULAR HEART DISEASE: A CASE REPORT3
164 HIGH HDL CHOLESTEROL INCREASES CARDIOVASCULAR RISK IN HYPERTENSIVE PATIENTS3
Clinical Efficacy Observation of Lacrimal Intubation Surgery for the Treatment of Lacrimal Passage Stenosis or Obstruction3
Factor XI inhibition in patients with acute coronary syndrome3
Transcatheter edge-to-edge repair for mitral regurgitation across age groups: a propensity-matched cohort study3
Percutaneous coronary intervention for left main coronary artery disease: temporal trends and in-hospital outcomes from a 12-year consecutive cohort3
Impact of guideline-directed medical therapy on outcomes of mitral transcatheter edge-to-edge repair3
1120 DIAGNOSTIC ACCURACY OF SMART GADGETS/WEREABLE DEVICES IN ATRIAL FIBRILLATION DETECTION: A METANALYSIS3
DESMOPLAKIN CARDIOMYOPATHY IN A PATIENT WITH LEFT BUNDLE BRANCH BLOCK: A CASE REPORT3
Does the short-term cardioprotection prevent diastolic dysfunction?3
Bruton tyrosine kinase inhibitors at the time of cardio-oncology: proving safety on right ventricular function and afterload3
Scarring/arrhythmogenic cardiomyopathy3
201 CTLA-4 AND PD-1 BLOCKING AGENTS INCREASES SYSTEMIC SDF-1, CARDIAC DAMPS FIBRONECTIN EDA, S-100 CALGRANULIN, GALECTINE-3 AND NLRP-3/MYD-88 CHEMOKINE PATHWAYS3
P437 HEART AND RHEUMATOLOGICAL DISEASE: A PICTURE OF ACUTE HEART FAILURE2
C80 GENETIC AND NON–GENETIC DETERMINANTS OF CLINICAL VARIABILITY IN A FAMILIAL CASE OF HYPERTROPHIC CARDIOMYOPATHY WITH HETEROZYGOUS PATHOGENIC MYPBC3 MUTATION2
CLINICAL AND GENETIC FEATURES OF JUVENILE ONSET LONE ATRIAL FIBRILLATION2
P142 EARLY MANAGEMENT OF STEMI PATIENTS DURING COVID–19 PANDEMIC: THE ROLE OF AN EMERGENCY DEPARTMENT–BASED CARDIOLOGY UNIT IN SAN RAFFAELE SCIENTIFIC INSTITUTE2
CARDIAC REMODELING AND OUTCOME AFTER SURGICAL INTERVENTION FOR ATRIAL FUNCTIONAL MITRAL REGURGITATION2
ST SEGMENT DEPRESSION: MUCH ADO ABOUT NOTHING2
May Measurement Month 2021: an analysis of blood pressure screening results from Nepal2
A novel sirolimus-coated balloon versus a paclitaxel-coated balloon for coronary artery disease: the SELSEQ registry2
Correlation analysis of Gensini score in T2DM patients with STEMI2
ANMCO position paper ‘Hypertrophic cardiomyopathy: from diagnosis to treatment’2
P192 POSTINFARCTION VENTRICULAR SEPTAL DEFECT: MANAGEMENT AND A NEW SURGICAL OPTION FOR CLOSURE2
P378 HEART FAILURE DURING ACUTE CORONARY SYNDROME AND THE LONG–TERM RISK OF INCIDENT CANCER. THE ABC–9* STUDY ON HEART DISEASE2
P212 EFFICACY AND SAFETY OF GENOTYPE–GUIDED AND PLATELET FUNCTION TEST–GUIDED ANTI–P2Y12 THERAPY IN PATIENTS UNDERGOING PCI: A META–ANALYSIS OF RCTS2
P44 IMPROVEMENT OF THE LEFT VENTRICULAR CONTRACTILE RESERVE IN PATIENTS UNDERGOING MITRAL VALVE PLASTIC CARDIAC SURGERY2
P315 GENETIC RESISTENCE TO CLOPIDOGREL AND COMPLEX PCI: A CASE REPORT2
The new in anticoagulation: factor XI inhibitors2
PLATYPNEA–ORTHODEOXIA SYNDROME SECONDARY TO TRAUMATIC TRICUSPID VALVE RUPTURE: A CASE REPORT2
Treating chronic kidney disease to reduce cardiovascular risk2
Cerebral haemorrhage in the patient with atrial fibrillation: do we employ the direct oral anticoagulants without waiting too long?2
The prognostic significance of microvascular resistance reserve: a systematic review and meta-analysis2
May Measurement Month 2023: results of an opportunistic blood pressure screening campaign in Republic of the Congo2
The diagnostic value of electrocardiogram in the left variants of desmosomal arrhythmogenic cardiomyopathy2
P366 FULMINANT MYOCARDITIS WITH SPONTANEOUS RESOLUTION AFTER COVID 19 AND ALLERGIC EPISODE: MIS–A OR ALLERGIC MYOCARDITIS?2
P453 RECURRENT SYNCOPAL EPISODES IN A YOUNG PATIENT: TO IMPLANT THE PM OR NOT TO IMPLANT THE PM, ALWAYS A DIFFICULT DECISION!2
P179 RISCONTRO ACCIDENTALE DI UN RARO CASO DI COR TRIATRIUM DESTRO ASSOCIATO A DIFETTO INTER–ATRIALE IN UN PAZIENTE ADULTO2
P139 RETURN TO THE ORIGINS: WHEN THE THROMBOLYSIS SAVES THE ANGIOPLASTY2
P230 A RARE CASE OF INFECTIVE MYOCARDIAL INFARCTION2
An aggressive solution for patients with heart failure and atrial fibrillation: nodal ablation and cardiac resynchronization therapy2
A NEW PROJECT OF A SPECIFIC EXERCISE PROTOCOL FOR AMBULATORY CARDIOVASCULAR REHABILITATION SPECIFIC FOR HEART FAILURE: REPORT OF THE FIRST EXPERIENCE2
593 PRESENTATION AND OUTCOME OF PATIENTS WITH COEXISTING CARDIAC AL AND ATTR AMYLOIDOSIS2
Screening for dilated cardiomyopathy in immediate family members: to whom, how, when (and where)2
Sex differences in characteristics and outcomes after TAVR-in-TAVR: the PANDORA international registry2
Present and future of endomyocardial biopsy in cardiac amyloidosis2
P353 A CASE OF FABRY DISEASE WITH ISOLATED CARDIAC INVOLVEMENT2
0.17784190177917